These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 668793)

  • 1. Oral antipyretic therapy: evaluation of the N-aryl-anthranilic acid derivatives mefenamic acid, tolfenamic acid and flufenamic acid.
    Keinänen S; Similä S; Kouvalainen K
    Eur J Clin Pharmacol; 1978 Jul; 13(5):331-44. PubMed ID: 668793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral antipyretic therapy. Evaluation of mefenamic acid (short communication).
    Similä S; Kouvalainen K; Keinänen S
    Arzneimittelforschung; 1977; 27(3):687-8. PubMed ID: 577447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of mefenamic acid and flufenamic acid in clinical pain.
    Ferris JE; Pigott PV
    Ann Phys Med; 1966; Suppl():84-6. PubMed ID: 4895009
    [No Abstract]   [Full Text] [Related]  

  • 4. Double-blind evaluation of the analgesic and toxic effects of flufenamic acid and mefenamic acid in patients with chronic pain.
    Kater RM
    Med J Aust; 1968 May; 1(20):848-51. PubMed ID: 5652895
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessment of drugs in out-patients with rheumatoid arthritis. Evaluation of methods and a comparison of mefenamic and flufenamic acids with phenylbutazone and aspirin.
    Mason RM; Barnardo DE; Fox WR; Weatherall M
    Ann Rheum Dis; 1967 Sep; 26(5):373-88. PubMed ID: 6039589
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical experience with a new antipyretic in children].
    Nissen G; Teubner W
    Monatsschr Kinderheilkd (1902); 1968 Mar; 116(3):105-7. PubMed ID: 5688128
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative bioassay of drugs in adjuvant-induced arthritis in rats: flufenamic acid, mefenamic acid, and phenylbutazone.
    Winder CV; Lembke LA; Stephens MD
    Arthritis Rheum; 1969 Oct; 12(5):472-82. PubMed ID: 5823918
    [No Abstract]   [Full Text] [Related]  

  • 8. Trial of prostaglandin-synthetase inhibitors in primary dysmenorrhoea.
    Anderson AB; Haynes PJ; Fraser IS; Turnbull AC
    Lancet; 1978 Feb; 1(8060):345-8. PubMed ID: 75391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fenamates and the potent inhibition of human liver phenol sulphotransferase.
    Vietri M; De Santi C; Pietrabissa A; Mosca F; Pacifici GM
    Xenobiotica; 2000 Feb; 30(2):111-6. PubMed ID: 10718119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinical trial of flufenamic acid in the treatment of rheumatoid arthritis.
    Cardoe N
    Ann Phys Med; 1966; Suppl():99-103. PubMed ID: 4895012
    [No Abstract]   [Full Text] [Related]  

  • 11. Antagonism by mefenamic and flufenamic acids of the bronchoconstrictor action of kinins in the guinea-pig.
    COLLIER HO; SHORLEY PG
    Br J Pharmacol Chemother; 1963 Apr; 20(2):345-51. PubMed ID: 14022332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ANTI-INFLAMMATORY AND ANTIPYRETIC PROPERTIES OF N-(2,6-DICHLORO-M-TOLYL)ANTHRANILIC ACID (CI-583).
    WINDER CV; WAX J; WELFORD M
    J Pharmacol Exp Ther; 1965 Jun; 148():422-9. PubMed ID: 14334278
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical trials of the fenamates. The value of computers in analysing clinical trials.
    Weatherall M
    Ann Phys Med; 1966; Suppl():77-83. PubMed ID: 4895008
    [No Abstract]   [Full Text] [Related]  

  • 14. Tolfenamic acid and mefenamic acid in the treatment of primary dysmenorrhoea.
    Delgado J; Simonin G; Servier C; García R; Yoma J
    Pharmacol Toxicol; 1994; 75 Suppl 2():89-91. PubMed ID: 7816793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Choice of antipyretic in children.
    Khubchandani RP; Ghatikar KN; Keny S; Usgaonkar NG
    J Assoc Physicians India; 1995 Sep; 43(9):614-6. PubMed ID: 8773063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Raman and IR spectroscopic studies of fenamates--conformational differences in polymorphs of flufenamic acid, mefenamic acid and tolfenamic acid.
    Jabeen S; Dines TJ; Leharne SA; Chowdhry BZ
    Spectrochim Acta A Mol Biomol Spectrosc; 2012 Oct; 96():972-85. PubMed ID: 22954807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of magnesium hydroxide on the absorption of tolfenamic and mefenamic acids.
    Neuvonen PJ; Kivistö KT
    Eur J Clin Pharmacol; 1988; 35(5):495-501. PubMed ID: 3266151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human metabolism of tolfenamic acid. II. Structure of metabolites and C-13 NMR assignments of fenamates.
    Khalifah RG; Hignite CE; Pentikäinen PJ; Penttilä A; Neuvonen PJ
    Eur J Drug Metab Pharmacokinet; 1982; 7(4):269-76. PubMed ID: 7166179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of adjuvant arthritis in rats with anti-inflammatory drugs.
    Winter CA; Nuss GW
    Arthritis Rheum; 1966 Jun; 9(3):394-404. PubMed ID: 5938055
    [No Abstract]   [Full Text] [Related]  

  • 20. Fenamates inhibit human sodium channel Nav1.7 and Nav1.8.
    Sun JF; Xu YJ; Kong XH; Su Y; Wang ZY
    Neurosci Lett; 2019 Mar; 696():67-73. PubMed ID: 30528877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.